Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced the appointment of P.L. Thomas (“PLT”) as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced today the appointment of P.L. Thomas as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Vitiva Names P.L. Thomas as Its Agent for the US and Canada
Slovenia-based Vitiva announced today the appointment of P.L. Thomas as its strategic partner for the sale of Vitiva products in the United States and Canada.
- Zila Releases Its Fiscal 2006 Second Quarter Financial Results
Company reports net revenues of $9.6 million compared to $10.9 million prior year, with Nutraceuticals revenue declining 2.6 million, or 26%, due to slower factory sales.
- Zila Releases Its Fiscal 2006 Second Quarter Financial Results
Company reports net revenues of $9.6 million compared to $10.9 million prior year, with Nutraceuticals revenue declining 2.6 million, or 26%, due to slower factory sales.
- Frutarom Reports 2005 Results
Company reports FY05 sales of US$ 243.8 million, a 23.9% increase compared with 2004, when sales reached US$ 196.8 million, as gross profit for the period rose 27% to reach US$ 94.5 million compared with US$ 74.3 million prior year.
- Frutarom Reports 2005 Results
Company reports FY05 sales of US$ 243.8 million, a 23.9% increase compared with 2004, when sales reached US$ 196.8 million, as gross profit for the period rose 27% to reach US$ 94.5 million compared with US$ 74.3 million prior year.
- Natrol Appoints New Chief Operating Officer
Company announces the appointment of Craig Cameron as the new Chief Operating Officer effective April 1, 2006.
- Natrol Appoints New Chief Operating Officer
Company announces the appointment of Craig Cameron as the new Chief Operating Officer effective April 1, 2006.
- Natrol Appoints New Chief Operating Officer
Company announces the appointment of Craig Cameron as the new Chief Operating Officer effective April 1, 2006.
- Natrol Appoints New Chief Operating Officer
Company announces the appointment of Craig Cameron as the new Chief Operating Officer effective April 1, 2006.
- Sunwin International Neutraceuticals Posts Financial Performance for 3rd Quarter of Fiscal 2006
Company reports revenues of $3.841 million for the third quarter ended January 31, 2006, compared to $2.705 million prior year, with net income of $877,588 versus $193,698 for the same period prior year.
- Sunwin International Neutraceuticals Posts Financial Performance for 3rd Quarter of Fiscal 2006
Company reports revenues of $3.841 million for the third quarter ended January 31, 2006, compared to $2.705 million prior year, with net income of $877,588 versus $193,698 for the same period prior year.
- Natren Appoints New Age Marketing to Represent Brand Across Canada
Company has appointed New Age Marketing Inc. to represent the Natren brand across Canada, representing Natren to the retail class of trade including natural foods stores, pharmacies, and mass market.
- Natren Appoints New Age Marketing to Represent Brand Across Canada
Company has appointed New Age Marketing Inc. to represent the Natren brand across Canada, representing Natren to the retail class of trade including natural foods stores, pharmacies, and mass market.
- Nurture, Inc. Announces Western U.S. Distribution Partner for OatVantage®
Company has announced a sales agent and distribution partnership with American Ingredients, Inc. (A.I.), a division of Pharmachem Laboratories, Inc., appointing A.I. as Nurture’s exclusive Western distributor.
- Nurture, Inc. Announces Western U.S. Distribution Partner for OatVantage®
Company has announced a sales agent and distribution partnership with American Ingredients, Inc. (A.I.), a division of Pharmachem Laboratories, Inc., appointing A.I. as Nurture’s exclusive Western distributor.
- Carotech Invests in New Plant, Reinforces its Leading Position & Largest Producer of Natural Tocotrienol Complex
company has announced its plan to invest USD 40 Million to build a new plant near a deep-sea port in Lumut, Malaysia.
- Carotech Invests in New Plant, Reinforces its Leading Position & Largest Producer of Natural Tocotrienol Complex
company has announced its plan to invest USD 40 Million to build a new plant near a deep-sea port in Lumut, Malaysia.
- Denomega Nutritional Oils and GAT Food Essentials Announce Exclusive OMEGA-3 Co-branding Agreement
Denomega Nutritional Oils (Denomega) and GAT Food Essentials (GAT) announced today agreements committing the parties to work closely together in the Omega-3 functional food and beverage markets. The agreements are effective March 23, 2006.
- Denomega Nutritional Oils and GAT Food Essentials Announce Exclusive OMEGA-3 Co-branding Agreement
Denomega Nutritional Oils (Denomega) and GAT Food Essentials (GAT) announced today agreements committing the parties to work closely together in the Omega-3 functional food and beverage markets. The agreements are effective March 23, 2006.
- Denomega Nutritional Oils and GAT Food Essentials Announce Exclusive OMEGA-3 Co-branding Agreement
Denomega Nutritional Oils (Denomega) and GAT Food Essentials (GAT) announced today agreements committing the parties to work closely together in the Omega-3 functional food and beverage markets. The agreements are effective March 23, 2006.
- New Patent For Biogaia In USA
Company has been granted a patent in the USA related to anti-inflammatory use of certain strains of probiotic lactobacilli.
- New Patent For Biogaia In USA
Company has been granted a patent in the USA related to anti-inflammatory use of certain strains of probiotic lactobacilli.
- Colgate Purchasing Tom’s of Maine - Enters Fast-Growing Natural Products Segment
The transaction will be structured as an all cash acquisition of 84 percent of the outstanding shares of Tom’s of Maine for an aggregate price of approximately $100 million, subject to adjustment at closing, with the Chappell family continuing to hold a 16% stake.
- Colgate Purchasing Tom’s of Maine - Enters Fast-Growing Natural Products Segment
The transaction will be structured as an all cash acquisition of 84 percent of the outstanding shares of Tom’s of Maine for an aggregate price of approximately $100 million, subject to adjustment at closing, with the Chappell family continuing to hold a 16% stake.
- Colgate Purchasing Tom’s of Maine - Enters Fast-Growing Natural Products Segment
The transaction will be structured as an all cash acquisition of 84 percent of the outstanding shares of Tom’s of Maine for an aggregate price of approximately $100 million, subject to adjustment at closing, with the Chappell family continuing to hold a 16% stake.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Integrated Genomics and DANONE Sign 3-Year ERGO License Deal
The Daniel Carasso Center, Groupe DANONE's Research Center, has entered into a 3-year license for Integrated Genomics’ ERGO® database and genomic discovery system, intend9ng to use the ERGO system as part of its tools to analyze genomic and microarray data from lactic acid bacteria.
- Omega Protein to Build New Technical Center for Development of Omega-3 Fatty Acid Products
Company is to build a new technical center to be located in Houston, Texas to further develop its OmegaPure(R) food grade Omega-3 product line. The facility is expected to be completed by mid-summer 2006.
- Omega Protein to Build New Technical Center for Development of Omega-3 Fatty Acid Products
Company is to build a new technical center to be located in Houston, Texas to further develop its OmegaPure(R) food grade Omega-3 product line. The facility is expected to be completed by mid-summer 2006.
- Natrol Appoints Eric P. Schick as Vice President of Marketing
Company announces the appointment of Eric P. Schick as Vice President of Marketing to be responsible for growth of the Company's key brands, Natrol(R), Laci Le Beau(R) and Prolab(R), within health food, mass market retail and other channels.
- Natrol Appoints Eric P. Schick as Vice President of Marketing
Company announces the appointment of Eric P. Schick as Vice President of Marketing to be responsible for growth of the Company's key brands, Natrol(R), Laci Le Beau(R) and Prolab(R), within health food, mass market retail and other channels.
- Natrol Appoints Eric P. Schick as Vice President of Marketing
Company announces the appointment of Eric P. Schick as Vice President of Marketing to be responsible for growth of the Company's key brands, Natrol(R), Laci Le Beau(R) and Prolab(R), within health food, mass market retail and other channels.
- Natrol Appoints Eric P. Schick as Vice President of Marketing
Company announces the appointment of Eric P. Schick as Vice President of Marketing to be responsible for growth of the Company's key brands, Natrol(R), Laci Le Beau(R) and Prolab(R), within health food, mass market retail and other channels.
- Great Ocean Joins the Planet Organic Market Family
Company announces the official name change of their Halifax store from "Great Ocean Natural Foods" to "Planet Organic Market."
- Great Ocean Joins the Planet Organic Market Family
Company announces the official name change of their Halifax store from "Great Ocean Natural Foods" to "Planet Organic Market."
- Lifeway Foods Reports Record Fourth Quarter, and 2005 Full Year Earnings Results
Company reports Q4 results with sales increasing 23% to $5,207,578 from $4,243,432 during the same period a year ago, as pre-tax income increased 63% to $1,059,401 from $648,905 during the same period a year ago.
- Lifeway Foods Reports Record Fourth Quarter, and 2005 Full Year Earnings Results
Company reports Q4 results with sales increasing 23% to $5,207,578 from $4,243,432 during the same period a year ago, as pre-tax income increased 63% to $1,059,401 from $648,905 during the same period a year ago.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Third Quarter Results
Company reports net sales of $49.6 million for the three months ended February 28, 2006, compared to $45.2 million for the same period in fiscal 2005, with income of $3.2 million, or $0.12 per share, compared to $1.2 million, or $0.05 per share, for the same period a year ago.
- Schiff Nutrition International, Inc. Announces Fiscal 2006 Third Quarter Results
Company reports net sales of $49.6 million for the three months ended February 28, 2006, compared to $45.2 million for the same period in fiscal 2005, with income of $3.2 million, or $0.12 per share, compared to $1.2 million, or $0.05 per share, for the same period a year ago.
- Holland Sweetener Company To Exit From Aspartame Business
Holland Sweetener Company VoF (HSC), a 50/50 joint venture between Royal DSM N.V. (the Netherlands) and Tosoh Corporation (Japan), hasannounced its decision to withdraw from the aspartame business, including Twinsweet.
- Holland Sweetener Company To Exit From Aspartame Business
Holland Sweetener Company VoF (HSC), a 50/50 joint venture between Royal DSM N.V. (the Netherlands) and Tosoh Corporation (Japan), hasannounced its decision to withdraw from the aspartame business, including Twinsweet.
- Holland Sweetener Company To Exit From Aspartame Business
Holland Sweetener Company VoF (HSC), a 50/50 joint venture between Royal DSM N.V. (the Netherlands) and Tosoh Corporation (Japan), hasannounced its decision to withdraw from the aspartame business, including Twinsweet.
- Holland Sweetener Company To Exit From Aspartame Business
Holland Sweetener Company VoF (HSC), a 50/50 joint venture between Royal DSM N.V. (the Netherlands) and Tosoh Corporation (Japan), hasannounced its decision to withdraw from the aspartame business, including Twinsweet.
- Holland Sweetener Company To Exit From Aspartame Business
Holland Sweetener Company VoF (HSC), a 50/50 joint venture between Royal DSM N.V. (the Netherlands) and Tosoh Corporation (Japan), hasannounced its decision to withdraw from the aspartame business, including Twinsweet.
- Natrol Announces Fourth Quarter, Full Year 2005 Results
Company reports a net loss for the three months ending December 31, 2005 was $1.6 million, or $0.12 per diluted share, with sales decreasing 14.0%, or $2.4 million, to $14.9 million, from $17.3 million for the same quarter in 2004.
- Natrol Announces Fourth Quarter, Full Year 2005 Results
Company reports a net loss for the three months ending December 31, 2005 was $1.6 million, or $0.12 per diluted share, with sales decreasing 14.0%, or $2.4 million, to $14.9 million, from $17.3 million for the same quarter in 2004.
- Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2005
Company reports total revenue of $21 million for year ended December 31, 2005 versus $17.6 million for year ended December 31, 2004, with a net loss of $0.38 per share, compared to a net loss of $0.25 per share for the prior year.
- Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2005
Company reports total revenue of $21 million for year ended December 31, 2005 versus $17.6 million for year ended December 31, 2004, with a net loss of $0.38 per share, compared to a net loss of $0.25 per share for the prior year.
- NutraCea Reports Fourth Quarter and Full Year Results
Company reports Q4 gross revenues of $4,504,000 compared to gross revenues of $561,000 prior year, with a net loss of $153,000 for the fourth quarter of 2005, compared to a net loss of $2,277,000 for the same period in 2004.
- NutraCea Reports Fourth Quarter and Full Year Results
Company reports Q4 gross revenues of $4,504,000 compared to gross revenues of $561,000 prior year, with a net loss of $153,000 for the fourth quarter of 2005, compared to a net loss of $2,277,000 for the same period in 2004.
- SourceOne(TM) Extends Exclusive Marketing Agreement For LJ100(TM) Tongkat Ali
SourceOne™ Global Partners has been awarded with an extension of its agreement for the rights to exclusively market and sell LJ100™ Tongkat Ali.
- SourceOne(TM) Extends Exclusive Marketing Agreement For LJ100(TM) Tongkat Ali
SourceOne™ Global Partners has been awarded with an extension of its agreement for the rights to exclusively market and sell LJ100™ Tongkat Ali.
- SourceOne(TM) Extends Exclusive Marketing Agreement For LJ100(TM) Tongkat Ali
SourceOne™ Global Partners has been awarded with an extension of its agreement for the rights to exclusively market and sell LJ100™ Tongkat Ali.
- SourceOne(TM) Extends Exclusive Marketing Agreement For LJ100(TM) Tongkat Ali
SourceOne™ Global Partners has been awarded with an extension of its agreement for the rights to exclusively market and sell LJ100™ Tongkat Ali.
- SourceOne(TM) Extends Exclusive Marketing Agreement For LJ100(TM) Tongkat Ali
SourceOne™ Global Partners has been awarded with an extension of its agreement for the rights to exclusively market and sell LJ100™ Tongkat Ali.
- SourceOne(TM) Extends Exclusive Marketing Agreement For LJ100(TM) Tongkat Ali
SourceOne™ Global Partners has been awarded with an extension of its agreement for the rights to exclusively market and sell LJ100™ Tongkat Ali.
- DSM Venturing makes follow-on investment in personalized nutrition company Sciona
Company announces that it has participated in a follow-on financing round of 6.5 million USD in the personalized nutrition company Sciona
- DSM Venturing makes follow-on investment in personalized nutrition company Sciona
Company announces that it has participated in a follow-on financing round of 6.5 million USD in the personalized nutrition company Sciona
- DSM Venturing makes follow-on investment in personalized nutrition company Sciona
Company announces that it has participated in a follow-on financing round of 6.5 million USD in the personalized nutrition company Sciona
- DSM Venturing makes follow-on investment in personalized nutrition company Sciona
Company announces that it has participated in a follow-on financing round of 6.5 million USD in the personalized nutrition company Sciona
- PacificHealth Laboratories, Inc. Reports Year End and Fourth Quarter 2005 Results
Company announces FY05 revenues of $5,444,558 compared to $6,807,271 for the same period in 2004, with a net loss of ($652,410), or ($0.06) per share for the year ended December 31, 2005 compared to a net loss applicable to common stockholders of ($2,521,096), or ($0.25) per share, for the prior year.
- PacificHealth Laboratories, Inc. Reports Year End and Fourth Quarter 2005 Results
Company announces FY05 revenues of $5,444,558 compared to $6,807,271 for the same period in 2004, with a net loss of ($652,410), or ($0.06) per share for the year ended December 31, 2005 compared to a net loss applicable to common stockholders of ($2,521,096), or ($0.25) per share, for the prior year.
- Sangster's Diversification with Gold's Gym Grows
Sangster's Health Centres, (a division of Planet Organic Health Corp.) has opened it's 48th store inside Regina's Gold's Gym.
- Sangster's Diversification with Gold's Gym Grows
Sangster's Health Centres, (a division of Planet Organic Health Corp.) has opened it's 48th store inside Regina's Gold's Gym.
- Natural Astaxanthin Detected in the Iris/Ciliary Body of the Eye
In a new study, natural astaxanthin extract (AstaREAL®) derived from Haematococcus microalgae was detected in the iris/ciliary body of New Zealand Albino (NZW) Rabbit Eyes 24 hours after ingestion.
- PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener
PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry.
- PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener
PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry.
- PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener
PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
|
Milwaukee, WI – The United States Patent and Trademark Office has issued a patent to Chr. Hansen for the "Purification process for improving total yield of curcuminoid coloring agent" under the patent number 6,942,881. Issued in late 2005, the patent pertains to a production process that improves the total yield of curcuminoids from turmeric and other curcuminoid-containing materials by 30-40 percent.
Curcumin is the primary pigment in the spice turmeric, and is typically used as a food color in dairy products, beverages, cereal, confectionary, ice cream, bakery, and savory products. In dairy, turmeric is mostly used in cultured milk, flavored milk drinks, and desserts to obtain lemon and banana colors. True to its original usage as a spice, turmeric is added at higher levels to sausages, pickles, relishes, sauces, dry mixes, and fish.
Well-documented studies have found the health benefits of curcumin include anti-inflammatory activity, cancer prevention, antimicrobial properties, and heart health including the lowering of cholesterol and triglyceride levels. Turmeric, mainly grown in Southeast Asia, has been used for centuries as a treatment for wounds and injuries in the Chinese and Ayurvedic systems of medicine. "With the growing consumer demand for more healthy foods and beverages, this patent is another illustration of Chr. Hansen's commitment to providing the food industry with natural ingredient solutions," states David R. Carpenter, President and CEO for Chr. Hansen in North America. He points out that it is another enhancement to the company's advanced production technology.
The newly issued patent is the latest in a number of patents Chr. Hansen owns on natural colors, as well as on starter cultures and lactic acid bacteria, enzymes, wine cultures, and other ingredients.
Operating from facilities in thirty countries worldwide, Chr. Hansen is a global biotechnology company that provides ingredients to the food, dairy, human health and nutrition, and animal health industries. Based on intensive research, Chr. Hansen works to improve the quality of food and health for people all over the world. The company is a primary supplier of cultures, probiotics, enzymes, colors, flavors, seasonings, sweeteners, and tablet coatings and excipients, which are applied in foods and beverages, pharmaceuticals, dietary supplements, and agricultural products. For more information, visit www.chr-hansen.com.
# # #
|